UChicago's Response to COVID-19


The University has created website resources that can be accessed by anyone who has questions about how the University is handling the COVID-19 pandemic:



Returning to Research: Update on Reopening Labs


The BSD is preparing to move into phase 2 of the research resumption plan, tentatively in mid-June. On June 3rd, Dr. Geoffrey Greene released a statement of BSD implementation guidelines.

BSD specific guidance on COVID-19


The health, safety and well-being of our BSD community, on and off-campus, is our top priority. We will continue to update the community regularly to keep you informed. Information on BSD-specific resources can be found here. Also please continue to consult the University and University of Chicago Medicine guidance as appropriate.

Appointment of Stephen Kron to Chair the Committee on Cancer Biology


We are pleased to announce that Stephen J. Kron, MD-PhD, Professor in the Department of Molecular Genetics & Cell Biology, has been appointed as Chair of the Committee on Cancer Biology, effective October 8th, 2019.


NCI renews funding for MTCR T32 for five more years


The National Cancer Institute (NCI) has renewed funding for the T32 training grant “Multi-disciplinary Training grant in Cancer Research (MTCR)” at the University of Chicago for another 5 years to support select graduate students at the University of Chicago working in cancer research focused projects.

Jessica Fessler wins NCI F99/K00


Fourth year CCB student Jessica Fessler was awarded a prestigious National Cancer Institute Predoctoral to Postdoctoral Transition Fellowship, "designed to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers." The award facilitates the transition of talented graduate students into successful cancer research postdoctoral appointments, and provides opportunities for career development activities relevant to their long-term career goals of becoming independent canc

Michelle M. Le Beau elected to the American Cancer Society Board of Directors


The American Cancer Society has named Michelle M. Le Beau, PhD, director of the University of Chicago Medicine Comprehensive Cancer Center, to its board of directors, with a term beginning on Jan. 1, 2019.

The full story is on Forefront.

BSD's Quantitative Biology Bootcamp awarded NSF funding


UChicago Biosciences' distinctive Quantitative Biology Bootcamp at MBL, now in its third year, has been awarded funding through the National Science Foundation (NSF). The award is part of the NSF's Innovations in Graduate Education (IGE) program. IN 2017, IGE funded ten projects that "pilot, test and validate" new methods in graduate education in science, technology, engineering and mathematics (STEM).

BSD makes GRE optional


Joining the ranks of more than 60 institutions and graduate programmes across the United States, the Biological Sciences Division has cut a standard test from its graduate admissions requirements. The decision aims to boost the likelihood of admission for minority and female applicants by levelling the playing field.

The full story is on NatureJobs.

GRIT in the News


The work of the UChicago recruitement student organization was profiled in Nature: International journal of science